BioSpace Movers and Shakers: Jan. 11

글 내용 전체보기

J&J Increases Prices As More Bills Are Filed in Congress to Lower Drug Costs

글 내용 전체보기

Amidst Restructuring and Executives Changes, AstraZeneca Lays off 210 in Colorado

글 내용 전체보기

JPM recap: Must-reads of the week, from FDA to IPO to M&A and more

글 내용 전체보기

FiercePharmaAsia—Pfizer plant closures; Gilead-Yuhan NASH pact; Fujifilm expansions

글 내용 전체보기

AstraZeneca lays off 210 workers in Colorado as it closes 2 ex-Amgen plants

글 내용 전체보기

Want to buy Clovis? Step up. ‘Everybody knows where to find me,’ CEO says

글 내용 전체보기

Teva shells out $135M to wrap Illinois AG’s Medicaid pricing fraud suit

글 내용 전체보기

First its CEO tells pharma to watch it on pricing—and then Johnson & Johnson raises them

글 내용 전체보기

Orchard Therapeutics’ 2019: Pipeline progress, breaking ground on its $90M manufacturing site

글 내용 전체보기

Adding a ‘switch’ to Cas9 to make CRISPR gene editing safer

글 내용 전체보기

Chutes & Ladders—Baselga to helm AstraZeneca’s cancer R&D

글 내용 전체보기

Deciphera CBO Morl talks lines of therapy for kinase inhibitor ripretinib

글 내용 전체보기

Univercells to scale-up sub 30 cent polio vaccine platform

글 내용 전체보기

Lack of large M&A not for the lack of trying, says Merck CEO

글 내용 전체보기

How Drugs Can Minimize the Side Effects of Chemotherapy

글 내용 전체보기

Chirality in ‘real-time’

글 내용 전체보기

Speeding up genetic diagnosis of Huntington’s disease

글 내용 전체보기

NIIMBL Announces New Projects and Funding for Biopharma Manufacturing

글 내용 전체보기

Gene Therapy Holds Promise for Blood Disorders

글 내용 전체보기

Brain Glial Cells Reprogrammed into Working Neurons

글 내용 전체보기